Chemspec draws stronger chemicals attendance

Chemspec draws stronger chemicals attendance

Chemspec Europe returned to Cologne with stronger specialist chemicals attendance. The event drew 4,238 attendees and 454 exhibitors from international fine and speciality chemicals markets.


Chemspec Europe returned to Cologne with 4,238 attendees from 60 nations and 454 exhibitors from 28 countries, marking a stronger gathering for the fine and speciality chemicals sector.

The 2026 event took place on 6 and 7 May, bringing together suppliers, manufacturers, buyers, distributors, and technical specialists across speciality chemistry. Conference and exhibition activity covered PFAS, biological crop protection, speciality formulation, regulatory pressure, and supply chain resilience.

Fine and speciality chemicals remain deeply embedded in industrial value chains. They support pharmaceuticals, coatings, electronics, agriculture, polymers, adhesives, advanced materials, personal care, and performance products. In many applications, the chemical supplier is not simply providing a material, but a functional ingredient, intermediate, additive, or process route that determines downstream performance.

The sector is operating under difficult European conditions. Energy cost exposure, feedstock volatility, weak demand in parts of manufacturing, import competition, and regulatory complexity have all affected chemical producers. Attendance growth at a specialist event therefore reflects continuing demand for technical relationships, compliance support, and innovation even where market conditions remain uneven.

Regulation is one of the strongest pressures on product development. PFAS restrictions, REACH obligations, classification rules, sustainability reporting, and customer-specific standards all influence formulation, sourcing, and market access. Companies have to maintain product performance while responding to regulatory scrutiny and customer demands for lower-impact materials.

Substitution work is rarely straightforward. Materials that attract regulatory attention are often used because they provide heat resistance, chemical resistance, durability, water repellence, process stability, low friction, or other critical properties. Replacing them requires formulation work, testing, qualification, customer validation, and sometimes changes in production processes.

The attention on biological crop protection reflects the same search for lower-impact chemistry. Agricultural, food, and materials markets all face pressure to reduce environmental burden, but industrial users still need reliability, supply continuity, and predictable performance. New chemistries have to move beyond laboratory promise and work at commercial scale under real handling, storage, application, and regulatory conditions.

Speciality chemicals also connect closely with pharmaceutical manufacturing. Intermediates, reagents, excipients, purification media, process chemicals, and analytical materials all influence development and production. The expansion of integrated biologics routes, including cell line development, process work, analytical testing, and GMP drug substance production, shows how high-value healthcare supply chains depend on disciplined chemical and bioprocess inputs.

Supply resilience remains high on the agenda. Downstream customers are looking beyond price to supplier reliability, regional availability, regulatory expertise, technical service, and documentation quality. A speciality chemical supplier able to solve formulation, compliance, and continuity problems can carry more value than one offering only volume.

Process engineering remains central to the sector’s ability to respond. New chemistries often require changes in handling, storage, reaction control, mixing, separation, waste treatment, cleaning, and quality testing. Scale-up can expose problems that are not visible in laboratory development, especially when raw material variability, heat transfer, impurity control, or plant compatibility become limiting factors.

The 2027 edition is scheduled for Messe Basel, keeping the event close to one of Europe’s strongest chemical and life sciences regions. That move should maintain its relevance to pharmaceutical, fine chemical, and speciality materials companies.

Chemspec’s stronger attendance points to a sector under pressure but still actively reshaping its technical base. Performance, compliance, supply resilience, and sustainability are now moving together, and the companies that can manage all four will shape the next phase of speciality chemicals manufacturing.


Stories for you


  • Chemspec draws stronger chemicals attendance

    Chemspec draws stronger chemicals attendance

    Chemspec Europe returned to Cologne with stronger specialist chemicals attendance. The event drew 4,238 attendees and 454 exhibitors from international fine and speciality chemicals markets.


  • Surventis launches from BASF Coatings

    Surventis launches from BASF Coatings

    Surventis has launched as an independent automotive coatings business today. The former BASF Coatings operation is backed by Carlyle and QIA, with BASF retaining 40%.